24 October 2021
1300 794 893

Tim Boreham

Tim Boreham is an experienced business writer, with over three decades at major business publications – covering sectors including; banking, accounting, resources, technology, telecoms, agribusiness, property trusts and life sciences.

22 October 2017
The new criterion: MGM Wireless and HUB24

MGM Wireless holds high hopes for its self-developed smart watch, while in the investment platform space HUB24 makes headway.

13 October 2017
The New Criterion: Stargroup

ATM operator Stargroup is hoping for a very nice withdrawal after the Big Four banks caved on foreign ATM fees.

7 August 2017
The New Criterion: Two small caps, come rain, hail or shine

If new IPO CropLogic has its way, it’s not just Eric Olthwaite who will be getting excited about rain gauges and precipitation. Meanwhile, Fluence is taking on the world’s polluted waterways.

31 July 2017
The New Criterion: Testing investor appetite for cobalt

Northern Cobalt’s upcoming IPO will test just how much investors still crave the battery metal. In the meantime, oil and gas explorer Whitebark is determined to prove there’s still a buck to be made out of dirty hydrocarbons.

25 July 2017
The New Criterion: Stocks exposed to the military machine

For two small caps exposed to the industrial military machine here and abroad, increased defence and anti-terrorism spending is a godsend.

17 July 2017
The New Criterion: All things that glisten are not silver

Investors are reeling from an unexplained sharp global sell off in the grey metal. For a handful of wannabe ASX-listed silver producers, it’s business as usual. Tim Boreham explains.

10 July 2017
The New Criterion: technology stocks

A robotics group has a machine that can lay 1000 bricks per hour, while another company is attempting to automate medical appointments, and also has some deep-pocketed friends.

3 July 2017
The New Criterion: drug development and computer viruses

A speed camera operator find more road blocks, while a cabal of Trump administration heavies discover the pitfalls of drug development.

25 June 2017
The New Criterion: Syrah Resources

Does graphite leader Syrah Resources’ imminent start to production at its giant Balama mine spell a new era of riches, or a glutted market? Meanwhile, Syrah’s old brigade seeks riches further afield.

19 June 2017
The New Criterion: Two stocks to watch

From thwarting terrorist attacks to helping divorcees snare an alimony payment, small-cap Veriluma has it covered. In the meantime, internet-of-things champion CCP will ensure the milk in the fridge doesn’t go off.

13 June 2017
The New Criterion: Oliver's Real Food and Eagle Health

Two new IPOs made it to the starting line last week, with both testing investor appetites for healthy products.

5 June 2017
The New Criterion: Pot stocks come down from high

For pot stock investors inhaling the wares on offer, it’s been a case of ‘too high, too quickly’ after a recent sharp sell-off.

Get the latest financial, business, and political expert commentary delivered to your inbox.

When you sign up, we will never give away or sell or barter or trade your email address.

And you can unsubscribe at any time!
1300 794 893
© 2006-2021 Switzer. All Rights Reserved. Australian Financial Services Licence Number 286531. 
homeshopping-cartphoneenvelopedollargraduation-cap linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram